ArticleBMC health services research2025
Barriers and enablers of elderly care specialists towards deprescribing practices in the nursing homes: a focus group study.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Healthcare professionals' perspectives of pharmacist roles in residential aged care: a qualitative systematic review and meta-synthesis.International journal of clinical pharmacy · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPolypharmacy increases as patients age. It is associated with a decline in quality of life and an increased risk of potentially inappropriate medications (PIMs). These are highly prevalent among long-term care residents in European countries. The potential benefits of deprescribing, as the process of withdrawing PIM’s are widespread, including improvements in both health and quality of life for patients. An overview of the barriers and enablers of deprescribing is still lacking in national research or policy discussions involving a larger group of Elderly Care specialist (ECS), who aim to maintain or improve the quality of life of elderly and chronically ill patients in the Netherlands. In this study, we explored the barriers and enablers of deprescribing among ECSs.
methodsA focus group study was conducted with two groups comprising a total of 11 ECSs. A theme list was prepared to guide the interviews. The audio recordings were transcribed verbatim by one and verified independently by another researcher. Analysis of the reports was carried out through thematic coding using Atlas.TI, performed independently by two researchers. After each step of the coding they were compared, verified and, if necessary, adjusted after consultation.
resultsECSs mentioned that gaining clinical experience and knowledge contributed to a positive attitude towards deprescribing. It is crucial to involve patients and their families and have support from care managers through official policy. Obstacles for deprescribing comprised lack of a medical history, the fear of the negative consequences of reducing medication, the lack of clinical guidelines regarding deprescribing, and the believe that a particular medication can be effective. The factor related to patient and family has a direct positive or negative impact on deprescribing if there is or is not cooperation.
conclusionDeprescribing in nursing home residents remains a challenge. The ECSs are both positive about and aware of its importance. At the same time the collaboration between all parties, including doctor and patient/family and other disciplines such as management and pharmacists and paramedics, was mentioned as a key working method in this regard.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.